Pleural effusion TGF-beta is highly diagnostic and prognostic in malignant pleural mesothelioma

Stockhammer, Paul; Ploenes, Till; Schüler, Martin; Langer, Sandra; Aigner, Clemens; Hegedűs, Balázs

doi:10.1093/annonc/mdz266.008

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Interestingly, TGFβ may be a potential marker for the diagnosis of MPM from patient pleural effusion, where TGFβ is highly diagnostic and prognostic, particularly in combination with measured mesothelin and IL-10 levels, which increase the sensitivity of the MPM diagnosis and allow stratifying patients in various survival subgroups [64][65][66].…”

Section: Tgfβ-induced Emt In Mpmmentioning

confidence: 99%

The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma

Ramundo

Zanirato

Aldieri

2021

IJMS

View full text Add to dashboard Cite

Malignant pleural mesothelioma (MPM) is an aggressive tumor mainly associated with asbestos exposure and is characterized by a very difficult pharmacological approach. One of the molecular mechanisms associated with cancer onset and invasiveness is the epithelial-to-mesenchymal transition (EMT), an event induced by different types of inducers, such as transforming growth factor β (TGFβ), the main inducer of EMT, and oxidative stress. MPM development and metastasis have been correlated to EMT; On one hand, EMT mediates the effects exerted by asbestos fibers in the mesothelium, particularly via increased oxidative stress and TGFβ levels evoked by asbestos exposure, thus promoting a malignant phenotype, and on the other hand, MPM acquires invasiveness via the EMT event, as shown by an upregulation of mesenchymal markers or, although indirectly, some miRNAs or non-coding RNAs, all demonstrated to be involved in cancer onset and metastasis. This review aims to better describe how EMT is involved in driving the development and invasiveness of MPM, in an attempt to open new scenarios that are useful in the identification of predictive markers and to improve the pharmacological approach against this aggressive cancer.

show abstract

Section: Tgfβ-induced Emt In Mpmmentioning

confidence: 99%